E2HC34 Stock Overview
Provides post-acute healthcare services in the United States and Puerto Rico.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Encompass Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$69.55 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.83 |
| 11 Month Change | 5.50% |
| 3 Month Change | 10.56% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 11.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| E2HC34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | 1.1% |
| 1Y | n/a | -6.3% | 8.5% |
Return vs Industry: Insufficient data to determine how E2HC34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how E2HC34 performed against the BR Market.
Price Volatility
| E2HC34 volatility | |
|---|---|
| E2HC34 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 9.1% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: E2HC34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine E2HC34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 26,003 | Mark Tarr | www.encompasshealth.com |
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services.
Encompass Health Corporation Fundamentals Summary
| E2HC34 fundamental statistics | |
|---|---|
| Market cap | R$35.04b |
| Earnings (TTM) | R$1.75b |
| Revenue (TTM) | R$23.08b |
20.6x
P/E Ratio1.6x
P/S RatioIs E2HC34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| E2HC34 income statement (TTM) | |
|---|---|
| Revenue | US$4.69b |
| Cost of Revenue | US$2.75b |
| Gross Profit | US$1.94b |
| Other Expenses | US$1.58b |
| Earnings | US$355.20m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 07, 2024
| Earnings per share (EPS) | 3.54 |
| Gross Margin | 41.35% |
| Net Profit Margin | 7.57% |
| Debt/Equity Ratio | 108.3% |
How did E2HC34 perform over the long term?
See historical performance and comparison